| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00198-018-4615-5 |
| P698 | PubMed publication ID | 30014156 |
| P2093 | author name string | J Bergman | |
| A Nordström | |||
| P Nordström | |||
| P2860 | cites work | Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis | Q37034834 |
| Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study | Q37046213 | ||
| Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research | Q38109833 | ||
| Comparative effectiveness of pharmacologic treatments to prevent fractures: an updated systematic review | Q38246980 | ||
| Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study | Q40313121 | ||
| Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients-a nationwide register-based open cohort study | Q42650607 | ||
| Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study | Q44625223 | ||
| Bisphosphonate use after clinical fracture and risk of new fracture | Q49350663 | ||
| Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women | Q56656398 | ||
| Reporting Statistical Information in Medical Journal Articles | Q73269788 | ||
| Comments on Bergman et al.: Bisphosphonate use after clinical fracture and risk of new fracture | Q89440548 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 2159-2160 | |
| P577 | publication date | 2018-07-16 | |
| P1433 | published in | Osteoporosis International | Q7107640 |
| P1476 | title | Bisphosphonate use after clinical fracture and risk of new fracture: response to comments by Wu et al | |
| P478 | volume | 29 |
Search more.